Q1 2023 Holdings
Filed 2023-05-15 | 43 holdings | $698.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $52.8M | 800,000 | 7.6% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $49.4M | 3,600,000 | 7.1% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $44.0M | 1,250,000 | 6.3% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $38.8M | 2,500,000 | 5.5% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $37.0M | 1,520,000 | 5.3% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $32.2M | 900,000 | 4.6% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $30.3M | 220,000 | 4.3% |
| Biogen Inc(BIIB) | COM | 09062X103 | $27.8M | 100,000 | 4.0% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $24.7M | 500,000 | 3.5% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $24.6M | 5,536,666 | 3.5% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $24.2M | 950,000 | 3.5% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $20.2M | 200,000 | 2.9% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $19.6M | 1,700,000 | 2.8% |
| Karuna Therapeutics Inc | COM | 48576A100 | $18.2M | 100,000 | 2.6% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $16.1M | 2,797,501 | 2.3% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $16.1M | 150,000 | 2.3% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $16.0M | 750,000 | 2.3% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $15.4M | 900,000 | 2.2% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $15.3M | 400,000 | 2.2% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $14.6M | 150,000 | 2.1% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $13.9M | 1,044,960 | 2.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $13.5M | 350,000 | 1.9% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $13.0M | 3,743,875 | 1.9% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $12.1M | 50,000 | 1.7% |
| Dice Therapeutics Inc | COM | 23345J104 | $11.7M | 410,000 | 1.7% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $11.1M | 525,000 | 1.6% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $10.8M | 1,000,000 | 1.5% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $9.6M | 700,000 | 1.4% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $9.0M | 270,000 | 1.3% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $8.8M | 401,229 | 1.3% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $8.3M | 350,000 | 1.2% |
| Geron Corp(GERN) | COM | 374163103 | $7.7M | 3,550,000 | 1.1% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $6.8M | 1,500,000 | 1.0% |
| Morphosys AG | SPONSORED ADS | 617760202 | $5.9M | 1,500,000 | 0.9% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $5.6M | 300,000 | 0.8% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $4.7M | 300,000 | 0.7% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $3.5M | 400,000 | 0.5% |
| Vigil Neuroscience Inc(VIGL) | COM | 92673K108 | $1.8M | 188,390 | 0.3% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $1.4M | 87,673 | 0.2% |
| Aligos Therapeutics Inc | COM | 01626L105 | $874.0K | 1,000,000 | 0.1% |
| Immunic Inc(IMUX) | COM | 4525EP101 | $627.6K | 421,184 | 0.1% |
| Lianbio | SPONSORED ADS | 53000N108 | $548.8K | 280,000 | 0.1% |
| Nuvation BIO Inc(NUVB/WS) | *W EXP 07/07/202 | 67080N119 | $8.0K | 66,666 | 0.0% |